Project Grant HT94252410438
Award Date
5/15/24
Completion Date
5/14/28
Dollars Obligated
$897K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes...
This $1,496,576.00 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support advanced biomedical research initiatives at Baylor College of Medicine in Houston, TX. The 4-year award, effective September 1, 2025 through August 31, 2029, will fund research on therapies for classical Ehlers-Danlos syndrome, a genetic disorder. As a prominent research university, Baylor College of Medicine has extensive expertise...
The U.S. Department of Defense's Defense Health Agency awarded a $1,200,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Baylor College of Medicine in Houston, Texas. The grant, effective April 1, 2025 through March 31, 2028, supports research to eliminate bone metastasis using a bone-targeting E-cadherin antibody nanogel. As a leading research institution, Baylor College of Medicine has extensive experience collaborating with federal agencies on...
This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
The Project Grant award of $440,000.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund research by Baylor College of Medicine on "Biopolymers for Intestinal Healing and Immune Modulation to Treat Inflammatory Bowel Disease." The award period runs from January 15, 2025 to January 14, 2027. This grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and...
The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
This $1,600,000.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Baylor College of Medicine focused on developing new synthetic lethal combination therapies targeting TopBP1 and the arachidonic acid pathway for breast cancer treatment. The three-year award, with an end date of February 28, 2027, will fund basic, translational, and clinical research aimed at advancing scientific understanding and...
The Department of the Army Medical Command awarded Baylor College of Medicine a $10,087,552 project grant from the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2022 to June 30, 2026. The grant funds research on combinatorial helper-dependent adenoviral gene therapy for post-traumatic osteoarthritis. Specifically, Baylor College of Medicine and sub-awardees Cornell University ($401,517 each) will conduct preclinical studies to assess the prevention...
This federal Project Grant award, valued at $802,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports preclinical gene therapy studies in a mouse model of TSC2 conducted by Baylor College of Medicine in Houston, Texas. The research aims to transform healthcare for military service members and the public through innovative and impactful biomedical research on genetic disorders. The award commenced on May 1,...
Baylor College of Medicine was awarded a $1.44 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research exploring connections between structural racism and children's health from August 1, 2023 through July 31, 2026. As the prime grantee, Baylor College of Medicine will leverage its expertise in medical research to investigate the relationship between structural racism and children's health...